Afalcytin, a proteinase with caseinolytic, arginine-esterase and amidase activities, was purified from the venom of Cprustes cerustes (horned viper) in two steps by gel filtration through Sephadex '375, then HPLC on carboxymethyl-cellulose. AfaBcytin has an isoelectric point of 6.25. and consists of two subunits, m and /], which have the same apparent molecular mass (40000) and are indistinguishable in the absence of reduction orkand deglycosylation. Subunit /) is constituted of two disulfide-linked polypeptidic chains, , O and f . The respective apparent molecular inass of the chains are 43000 (u), 35500 (/)) and 10200 (p') as determined by SDS/PAGE under reducing conditions. Both chains a and / l are N-glycosylated. The two chains have the same N-terminal sequence (20 residues) which is similar to those of other proteinases from snake venom. Susceptibility of afalcytin to diisopropyl fluorophosphate and benzamidine indicates the presence of a serine and an aspartic (or glutamic) acid residues in the catalytic site.Ca'+ appears to be required for structural cohesion of the afaBcytin molecule. Afalcytin exhibits apfibrinogenase and rx-fibrinase properties. It replaces missing factors VIII and IX in deficient plasmas, and activates purified human factor X into factor Xa. It releases serotonin from platelets and directly aggregates human (but not rabbit) blood platelets. Despite its thrombin-like characteristics, however, afalcytin is not inhibited by plasmatic thrombin inhibitors. The procoagulant properties of afalcytin therefore have potential clinical applications.